Butabarbital will lower the extent or result of fedratinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Steer clear of or Use Alternate Drug. Impact of coadministering a robust CYP3A4 inducer with fedratinib has not been examined. butabarbital will minimize the extent or impact of fosphenytoin by influencing hepatic enzyme CYP2C9/ten metabolism. https://silasg801fil7.is-blog.com/profile